|
| Inhibition | Sources | References |
|
| (1) Toxicity test | Rhizomes | Saraithong et al. [40] |
| Charoensin et al. [41] |
|
| (2) Antimicrobial activities | | |
| (A) Anti-Helicobacter pylori activity | Rhizomes | Bhamarapravati et al. [42] |
| Mahady et al. [43] |
(B) Pathogenic and spoilage bacteria inhibition activities
| Rhizomes | Pattaratanawadee et al. [44] |
| Rukayadi et al. [45] |
| (C) Antiamoebic activity for HIV patients | Rhizomes | Sawangjaroen et al. [46] |
|
| (3) Antiparasitic activity | | |
| Antigiardial activity | Rhizomes | Sawangjaroen et al. [47] |
|
| (4) Oral infections | | |
| (A) Inhibition of biofilm formation by oral pathogens | Rhizomes | Limsuwan and Voravuthikunchai, [48] |
| Yanti et al. [49] |
| (B) Antiperiodontitis activity of B. rotunda extract | | Yanti et al. [49, 50] |
| (C) Inhibition of Candida albicans | Dried plant | Cheeptham and Towers, [51] |
| Taweechaisupapong et al., [52] |
| (D) Anticariogenic | Rhizomes | Hwang et al. [53, 54] |
| (E) Candida adhesion inhibitor | Rhizomes | Sroisiri and Boonyanit, [55] |
| (F) Antihalitosis | Rhizomes | Hwang et al. (patented) [56] |
|
| (5) Inhibition of biofilm formation by intestinal pathogens | Rhizomes | Rukayadi et al. [57] |
|
| (6) Antioxidant activities | | |
| (A) Inhibition of lipid peroxidation in brain | Rhizomes | Shindo et al. [29] |
(B) Inhibition of oxidative damages by -butylhydroperoxide (t-BHP)
| Rhizomes | Sohn et al. [58] |
|
| (7) Antiulcer effect | Rhizomes | Abdelwahab et al. [59] |
|
| (8) Obesity treatment | Rhizomes | Kim et al. [60] |
|
| (9) Antimutagenic effect | Rhizomes | Trakoontivakorn et al. [23] |
|
| (10) Antitumour necrosis factor alpha (anti-TNF-) | Rhizomes | Morikawa et al. [35] |
|
| (11) Anticancer/antitumour | | |
| (A) Breast cancer and colon cancer prevention | Roots and rhizomes | Kirana et al. [61] |
| Zaeoung et al. [28] |
| Kirana et al. [62] |
|
Ling et al. [63]
|
| (B) Inhibition of prostate cancers | Rhizomes | Yun et al. [64] |
| (C) Antilung cancer | Rhizomes | Cheah et al. [65] |
| (D) Antileukemia | Rhizomes | Sukari et al. [34] |
|
| (12) Antifungal activities | | |
| (A) Antifungal activities against AIDS-related fungal infections | Rhizomes | Phongpaichit et al. [66] |
(B) Inhibition of spoilage and aflatoxin producing fungi
| Rhizomes | Pattaratanawadee et al. [44] |
|
| (13) Inhibition of Ca2+ signal in yeast model | Rhizomes | Wangkangwan et al. [67] |
|
| (14) Antiviral activities | | |
| (A) Anti-HIV-1 protease activity | Rhizomes | Tewtrakul et al. [26, 27] |
| Cheenpracha et al. [30] |
| (B) Inhibition of dengue NS2B/NS3 protease | Rhizomes |
Tan et al. 2006 |
| (C) Antifoot and mouth disease virus | Rhizomes | Chungsamarnyart et al. [68] |
|
| (15) Anti-inflammatory | | |
| (A) TPA-induced ear oedema | Rhizomes | Tuchinda et al. [25] |
| (B) Inflammation by nitric oxide (NO), prostaglandin E2 (PGE2), and tumour necrosis factor alpha (TNF-α) | Rhizomes | Tewtrakul et al. [69] |
| (C) Anti-inflammation effect caused by | Rhizomes (powder) | Boonjaraspinyo et al. [70] |
|
| (16) Inhibition of platelet-activating factor (PAF) receptor binding effect | Rhizomes | Jantan et al. [71] |
|